A new era for childhood cancer research
29 June 2026
The Department of Paediatrics at the University of Oxford has appointed Professor Isidro Cortés-Ciriano as its first Little Princess Trust Professor of Paediatric Oncology, marking a major milestone in a partnership dedicated to accelerating the development of new treatments for children with cancer.
Oxford researchers awarded ARIA funding to develop transformative anti-viral therapies
26 June 2026
Three innovative research projects aimed at transforming how we protect against respiratory viruses, led by teams at the University of Oxford, have secured funding through the UK’s Advanced Research and Invention Agency (ARIA).
New Oxford calculator shows serious statin muscle side effects are rare for most people
26 June 2026
Researchers at the Nuffield Department of Primary Care Health Sciences, University of Oxford, have developed a new calculator that estimates a person's risk of developing serious muscle disorders from statins. The tool could help patients and clinicians make more informed decisions about using these widely prescribed medications to prevent heart attacks and strokes.
Smoking and drinking exacerbate social inequalities in premature deaths in India
25 June 2026
Study finds social inequality is a major predictor of premature death, even among people who neither smoke nor drink alcohol.
Oxford research showcased at House of Commons pancreatic cancer event
25 June 2026
Mr Keaton Jones, Senior Clinical Researcher at the Nuffield Department of Surgical Sciences, attended 'Driving Treatment Breakthroughs', a Pancreatic Cancer UK parliamentary reception held at the House of Commons on 16 June 2026.
Two Dunn School researchers awarded 2026 Lister Prize
24 June 2026
Many congratulations to Anjali Hinch and Girish Mali in the Sir William Dunn School of Pathology for this prestigious honour, recognising researchers in the early years of establishing their groups.
Oxford University and King’s College London Join IMPACT Network Study to Advance Understanding of Profound Autism
24 June 2026
The University of Oxford and King’s College London (King’s) have joined the Innovative Medicine and Precision Approaches to Clinical Trials (IMPACT) Network, an international collaboration of sites working together to accelerate clinical trial readiness and therapeutic development for autism through a large-scale natural history and clinical endpoint study.
Fourteen Oxford academics awarded major European Research Council Advanced Grants
23 June 2026
Today, fourteen researchers at the University of Oxford, including four from Medical Sciences, were awarded Advanced Grants from the European Research Council (ERC), each worth up to €2.5 million over a period of five years.
Study reveals rare genetic variants that shape unexpected traits and health outcomes
23 June 2026
New study reveals why some people defy genetic expectations, offering insights into rare diseases and future treatments.
Natural compound may help boost vaccine responses in older adults
23 June 2026
Researchers from the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) have found that a naturally occurring compound called spermidine may help improve vaccine responses in some older adults by reducing signs of immune system ageing.
Equal funding transformed GP teaching, first evidence finds – now its gains need protecting
22 June 2026
The first study of England's harmonised education tariff finds equal funding has expanded GP placements and strengthened teaching quality – and identifies what must be protected as NHS England's functions transfer to the Department of Health and Social Care.
Kneecap resurfacing during knee replacement should be the standard procedure, new study finds
17 June 2026
The largest and longest clinical trial of its kind has found that resurfacing the kneecap during total knee replacement is likely to be the most cost-effective approach for patients and healthcare systems over the long term.
Warneford Park: Mental health and medical research campus development gets green light from Oxford City Council
17 June 2026
Plans to create a £750m mental health and medical research campus in Oxford have been given the go-ahead by Oxford City Council.
New Oxford Centre for Women’s Mental Health established
17 June 2026
The University of Oxford is set to launch a new research centre dedicated to women’s mental health, bringing together expertise from medical and biological sciences with humanities for the first time.
Expert Comment: Social media and AI chatbot limits for children - what does the evidence support?
16 June 2026
This week the UK government announced a ban on social media for under-16s and new age limits on romantic and sexual AI chatbots, following the precedent set by Australia. Researchers from the University of Oxford's Department of Psychiatry welcome the focus on children's online safety, but argue that age limits alone are a limited safeguard, and that protecting children depends more on how platforms and AI systems are designed than on who can reach them.
Professor Adam Mead appointed as Director of Oxford Cancer
15 June 2026
Oxford Cancer is delighted to announce the appointment of Professor Adam Mead as Director, joining Professors Mark Middleton and Tim Elliott in leading Oxford’s interdisciplinary cancer research community.
New biomarker brings personalised Polθ inhibitor-radiotherapy treatment closer to the clinic
14 June 2026
A new study led by Professor Geoff Higgins at the Department of Oncology, in collaboration with Artios Pharma, has uncovered a genetic vulnerability that could help identify patients most likely to benefit from a promising radiotherapy combination treatment. Published today in Science Advances, the research identifies loss of SHLD2 as a predictive biomarker for treatment with DNA polymerase theta (Polθ) inhibitors, an emerging class of DNA repair-targeted drugs.
Scientists in the Department of Paediatrics discover antibody combinations that block over 90% of malaria parasite growth
12 June 2026
In an important discovery for the next-generation of malaria vaccines, University of Oxford researchers in the Department of Paediatrics, in collaboration with the Scripps Institute, have identified how antibodies can be over 90% effective at preventing malaria parasites from growing in certain combinations.
Medical Sciences celebrates success at Vice-Chancellor’s Awards 2026
12 June 2026
The winners of the 2026 Vice-Chancellor’s Awards were announced at a special ceremony hosted by the Vice-Chancellor in the Schwarzman’s Sohmen Concert Hall on Thursday 4 June.
New Lancet Series outlines roadmap to end preventable maternal deaths from postpartum haemorrhage
12 June 2026
Leading experts from the University of Oxford and the World Health Organization are calling on the global community to invest in affordable proven solutions and change policy to end preventable deaths from bleeding during childbirth.